Asahi Life Asset Management Co., Ltd. Biogen Inc. Transaction History

Asahi Life Asset Management Co., Ltd.

$161 Million
Q4 2024

A detailed history of Asahi Life Asset Management Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Asahi Life Asset Management Co., Ltd. holds 2,285 shares of BIIB stock, worth $321,956. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,285

Previous 1,800 26.94%

Holding current value

$321,956

Previous $348,000 0.29%

% of portfolio

0.22%

Previous 0.21%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$146.47 - $191.55 $71,037 - $92,901	485 Added 26.94%	2,285 $349,000
Q3 2024 Oct 24, 2024	BUY	$189.07 - $236.8 $340,326 - $426,240	1,800 New	1,800 $348,000
Q1 2024 May 03, 2024	BUY	$212.02 - $267.71 $351,953 - $444,398	1,660 New	1,660 $357,000
Q1 2023 May 01, 2023	SELL	$256.56 - $292.34 $3,848 - $4,385	-15 Reduced 1.13%	1,310 $364,000
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $130,006 - $157,960	-515 Reduced 27.99%	1,325 $366,000
Q3 2022 Nov 07, 2022	BUY	$194.69 - $268.46 $1,946 - $2,684	10 Added 0.55%	1,840 $491,000
Q2 2022 Aug 02, 2022	BUY	$187.54 - $223.02 $343,198 - $408,126	1,830 New	1,830 $373,000
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $519,913 - $609,108	-2,140 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $70,878 - $106,689	300 Added 16.3%	2,140 $524,000
Q3 2020 Nov 02, 2020	BUY	$264.77 - $305.71 $209,168 - $241,510	790 Added 75.24%	1,840 $522,000
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $271,593 - $359,677	1,050 New	1,050 $281,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $494,684 - $627,513	-1,840 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $57,215 - $79,058	-260 Reduced 12.38%	1,840 $546,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $2,174 - $2,438	10 Added 0.48%	2,100 $489,000
Q2 2019 Aug 09, 2019	BUY	$219.29 - $241.72 $458,316 - $505,194	2,090 New	2,090 $489,000

Others Institutions Holding BIIB

# of Institutions

1,007

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.

Account

Asahi Life Asset Management Co., Ltd. Biogen Inc. Transaction History